IRVINE, Calif., April 25, 2017 -- Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against U.S. Concrete, Inc. (“U.S. Concrete” or the “Company”) (Nasdaq:USCR). Investors who purchased or otherwise acquired shares between March 6, 2015 and March 23, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the May 30, 2017 lead plaintiff motion deadline.
If you purchased U.S. Concrete shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
According to the Complaint, U.S. Concrete made false and misleading statements and/or failed to disclose that the Company lacked effective internal controls over financial reporting, and thus its public statements were materially false and misleading at all relevant times. On March 24, 2017, U.S. Concrete filed a Current Report on Form 8-K with the Securities & Exchange Commission, announcing the resignation of its CFO Joseph Tusa, and advising investors that the Company replaced its previous auditor, Grant Thornton LLP, with Ernst & Young LLP as its new public accounting firm. When this information was released to the public, shares of the Company dropped in value materially, which caused investors harm.
If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at [email protected].
This press release may constitute Attorney Advertising in certain jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 [email protected]


Samsung Electronics Shares Jump on HBM4 Mass Production Report
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



